This is to inform the exchange that the meeting of Board of Directors of the M/s. Bacil Pharma Limited has been duly convened on Tuesday 15th day of September 2020 at the registered office of the Company. The Board transacted following items:
Approved and adopted the un-audited Financial Results of the Company for the Quarter ended 30th June 2020.
Approved Limited Review Report for the Quarter ended 30th June 2020.